U.S. clears AstraZeneca over heart drug trial
August 19, 2014 at 02:31 AM EDT
LONDON, Aug 19 (Reuters) - AstraZeneca said on Tuesday the U.S. government was closing a probe into a major clinical trial used to win marketing approval for its new heart drug Brilinta and no further action was planned.